← Back to Search

Device

Inspiratory Muscle Training (IMT) for Respiratory Muscle Training

N/A
Recruiting
Led By Simon Ho
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age range 6-12 years of age
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial aims to investigate whether a specialized breathing muscle training program can improve how children regulate their breathing during exercise.

Who is the study for?
This trial is for typically developing children between the ages of 6 and 12. It aims to explore a training program designed to strengthen the muscles used for breathing.Check my eligibility
What is being tested?
The study tests the POWERbreathe Plus IMT device, which is intended to improve respiratory muscle function. Researchers will examine its impact on children's breathing regulation during exercise.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include temporary breathlessness or fatigue due to the nature of inspiratory muscle training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 6 and 12 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to treatment protocol
Percent completion
Secondary outcome measures
Diaphragm thickness (measured in mm)
Exercise ventilation
Maximal inspiratory pressure (measured in cm H2O)
Other outcome measures
6-minute walk test distance (measured in m)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Inspiratory Muscle Training (IMT)Experimental Treatment1 Intervention
Participants will be asked to perform inspiratory muscle training (breathing exercise) 5 days per week for 6 weeks at home.

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
688 Previous Clinical Trials
374,643 Total Patients Enrolled
Simon HoPrincipal InvestigatorUniversity of Maryland, Baltimore
1 Previous Clinical Trials
13 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit for the number of participants involved in this medical study?

"Indeed, the details on clinicaltrials.gov indicate that recruitment is ongoing for this investigation. The study was initially made public on February 1st, 2024 and last revised on February 6th, 2024. In total, the study aims to recruit a cohort of 13 participants from a single designated site."

Answered by AI

Are there any available slots for patients to participate in this research study?

"Yes, the details on clinicaltrials.gov show that this trial is actively seeking candidates. It was initially listed on February 1st, 2024, and most recently revised on February 6th, 2024. The study aims to enroll a total of 13 participants at one location."

Answered by AI

Does this clinical trial allow participation by individuals who are older than 85 years?

"To meet the trial's eligibility criteria, participants must be between 6 and 12 years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Diaphragm Structure and Function in Children
Simon Ho 2024. "Diaphragm Structure and Function in Children". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06230692.
~9 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top